Perspective Therapeutics, Inc. — Director's Dealing 2010

Oct 18, 2010

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2010-10-07

Reporting Person: Swindler Fredric (Vice President)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$4.4	2017-03-02	common stock (10000)		Direct
Stock Option	$4.14	2017-06-01	common stock (10000)		Direct
Stock Option	$0.65	2018-07-01	common stock (10000)		Direct
Stock Option	$0.26	2019-06-01	common stock (50000)		Direct
Stock Option	$1.43	2019-06-01	common stock (20000)		Direct

Footnotes

F1: 1/3 vested on 3/2/2008, 1/3 vested on 3/2/2009, and 1/3 vested on 3/2/2010.

F2: 1/3 vested on 6/1/2008, 1/3 vested on 6/1/2009, and 1/3 vested on 6/1/2010

F3: 1/3 vested on 7/1/ 2009, 1/3 vested on 7/1/2010, and 1/3 will vest on 7/1/2011.

F4: 1/3 vested on 6/1/2010, 1/3 will vest on 6/1/2011, and 1/3 will vest on 6/1/2012.

F5: 1/3 will vest on 6/30/2011, 1/3 will vest on 6/30/2012, and 1/3 will vest on 6/30/2013.